2024 ESC Guidelines on the treatment of chronic coronary syndrome — unanswered questions regarding antianginal medical therapy recommendations. A position paper of the ELECTRA-SIRIO 2 investigators
According to the 2024 ESC guidelines for the management of chronic coronary syndrome antianginal medical therapy aims to control symptoms while ensuring acceptable tolerability and patient adherence. The guidelines specify the indications for particular groups of antianginal drugs, defining the class of indications and the level of evidence based on the results of expert opinions, registries, clinical studies, and meta-analyses. This very important document has a great impact on clinical practice as it constitutes the basis for therapeutic decisions. Therefore, it is worth understanding the assumptions that guided the authors when formulating specific recommendations. As the investigators of the ELCTRA -SIRIO 2 trial*, we are monitoring new scientific evidence and new guidelines that may impact our study protocol.
Authors
- Tomasz Hajdukiewicz
- Agnieszka Tycińska (ORCID: https://orcid.org/0000-0001-7855-7261)
- Jakub Foryś
- Piotr Adamski (ORCID: https://orcid.org/0000-0001-9719-0987)
- Przemysław Podhajski (ORCID: https://orcid.org/0000-0003-0525-1557)
- Wacław Kochman (ORCID: https://orcid.org/0000-0002-7706-0648)
- Eliano Pio Navarese (ORCID: https://orcid.org/0000-0002-2355-4589)
- Wiktor Kuliczkowski (ORCID: https://orcid.org/0000-0001-6284-0820)
- Miłosz Jaguszewski (ORCID: https://orcid.org/0000-0002-2555-593X)
- Piotr Niezgoda (ORCID: https://orcid.org/0000-0002-9912-9730)
- Przemysław Mitkowski (ORCID: https://orcid.org/0000-0001-9309-674X)
- Przemysław Magielski
- Piotr Jankowski (ORCID: https://orcid.org/0000-0001-6223-8821)
- Mariusz Gąsior (ORCID: https://orcid.org/0000-0001-6775-1392)
- Julia M. Umińska (ORCID: https://orcid.org/0000-0003-2309-2369)
- Marek Gierlotka (ORCID: https://orcid.org/0000-0001-5639-2128)
- Ewa Laskowska (ORCID: https://orcid.org/0000-0002-5940-7951)
- Małgorzata Ostrowska (ORCID: https://orcid.org/0000-0002-3377-2950)
- Aldona Kubica (ORCID: https://orcid.org/0000-0002-4608-0881)
- Jacek Kubica (ORCID: https://orcid.org/0000-0001-8250-754X)
- Robert Gil (ORCID: https://orcid.org/0000-0002-9041-3313)
- Aleksander Żurakowski (ORCID: https://orcid.org/0000-0002-5135-6598)
- Tomasz Fabiszak (ORCID: https://orcid.org/0000-0001-7317-5088)
- Janina Stępińska (ORCID: https://orcid.org/0000-0001-5687-1292)
- Piotr Buszman (ORCID: https://orcid.org/0000-0003-1158-1325)
- Robert Gajda (ORCID: https://orcid.org/0000-0002-8305-8130)
- Maciej Piasecki (ORCID: https://orcid.org/0000-0002-6626-3618)
- Jacek Konarski
- Piotr Michalski (ORCID: https://orcid.org/0000-0001-9667-6096)
- Maciej Lesiak
- Grzegorz Skonieczny
- Natalia Mrzywka
- Alicja Rzepka-Cholasińskia
Institutions
- Poznan University of Medical Sciences (PL)
- Jan Długosz University (PL)
- Medical University of Białystok (PL)
- University of Sassari (IT)
- Medical University of Silesia (PL)
- University of Opole (PL)
- Nicolaus Copernicus University (PL)
- Wroclaw Medical University (PL)
- State University of Applied Sciences in Elbląg (PL)
- Silesian Center for Heart Disease (PL)
- Postgraduate School of Molecular Medicine (PL)
- Institute of Cardiology (PL)
- American Heart of Poland (PL)
- Andrzej Frycz Modrzewski Krakow University (PL)
- Provincial Polyclinical Hospital in Toruń (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Medical Research Journal
- Published
- 2024-12-31
- DOI
- https://doi.org/10.5603/mrj.103601
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00